Search Results 2251-2260 of 16204 for Epilepsy (Partial Onset)

  1. Chronic Abdominal Wall Pain

    So again, a positive Carnett sign would be someone who has worsening of their abdominal tenderness in a focal area with tensing of their abdominal wall ...

  2. Publications - Yael N. Kusne, M.D., Ph.D. - Mayo Clinic

    Reduced posterior cingulate mitochondrial activity in expired young adult carriers of the APOE epsilon4 allele, the major late-onset Alzheimer's susceptibility ...

  3. Efficacy and Safety of Benralizumab in Patients With Non-cystic Fibrosis Bronchiectasis - Mayo Clinic

    The purpose of this study is to test the hypothesis that benralizumab will reduce exacerbation rates compared with placebo on top of standard-of-care therapy in ...

  4. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16) - Mayo Clinic

    ... duration of the study and for at least 16 weeks (112 days) after the last ... duration of the study are eligible). 12. Any of the following clinical ...

  5. Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-OLE) - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the study, and at least 30 days after discontinuing study drug.

  6. Telehealth Assessments With Glioma Receiving Oral Chemotherapy - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. ... duration of the study. Participants who do not have financial resources to ...

  7. Neurology - Clinical trials

    ... epilepsy. Analyses of Metabolic Agents Following Brain Radiation. Rochester, Minn. The purpose of this study is to determine the feasibility of serial ...

  8. A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3) - Mayo Clinic

    Participants with AD duration of at least 3 months (participant/parent/guardian may verbally report signs and symptoms of AD with onset at least 3 months prior) ...

  9. An Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BIIB067 in Adults With Inherited Amyotrophic Lateral Sclerosis (ALS) (VALOR (Part C)) - Mayo Clinic

    ... onset):; p.Ala5Val, p.Ala5Thr, p.Leu39Val, p.Gly42Ser, p.His44Arg, p.Leu85Val, p.Gly94Ala, p.Leu107Val, and p.Val149Gly; OR; SOD1 mutation other than those ...

  10. Itchy Skin Clinical Trials - Mayo Clinic Research

    Subjects on GSK2330672 will also receive placebo tablets to maintain blinding. The total duration of a subject's participation will be up to 45 days of ...